Exposure to Fine Particulate Air Pollution Is Associated with Endothelial Injury and Systemic Inflammation

Circulation Research

Volumn 119, Issue 11, 2016, Pages 1204-1214

  Pope, C Arden ^a   Bhatnagar, Aruni ^b   McCracken, James P ^b   Abplanalp, Wesley ^b   Conklin, Daniel J ^b   O'Toole, Timothy ^b  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

air pollution; cardiovascular disease; inflammation; particulate matter; vascular disease

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBRINOGEN RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOCORTIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; RANTES; TUMOR NECROSIS FACTOR; VASCULOTROPIN; AUTACOID; OMEGA 3 FATTY ACID; PARTICULATE MATTER;

ADULT; AIR POLLUTION; ARTICLE; BLOOD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM INJURY; ENVIRONMENTAL EXPOSURE; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE AGGREGATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PARTICULATE MATTER; PRIORITY JOURNAL; SYSTEMIC DISEASE; THROMBOCYTE AGGREGATION; YOUNG ADULT; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PARTICLE SIZE; RANDOMIZATION; VASCULAR ENDOTHELIUM;

ADULT; AIR POLLUTION; ENDOTHELIUM, VASCULAR; ENVIRONMENTAL EXPOSURE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; PARTICLE SIZE; PARTICULATE MATTER; RANDOM ALLOCATION; YOUNG ADULT;

EID: 84994165737     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309279     Document Type: Article

References (64)

1. Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378. doi: 10.1161/ CIR.0b013e3181dbece1.
2. Franklin BA, Brook R, Arden Pope C III. Air pollution and cardiovascular disease. Curr Probl Cardiol. 2015;40:207-238. doi: 10.1016/j. cpcardiol.2015.01.003.
3. Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329:1753-1759. doi: 10.1056/ NEJM199312093292401.
4. Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287:1132-1141.
5. Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356:447-458. doi: 10.1056/NEJMoa054409.
6. Kaufman JD, Adar SD, Barr RG, et al. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study. Lancet. 2016;388:696-704. doi: 10.1016/ S0140-6736(16)00378-0.
7. Brook RD, Cakmak S, Turner MC, Brook JR, Crouse DL, Peters PA, van Donkelaar A, Villeneuve PJ, Brion O, Jerrett M, Martin RV, Rajagopalan S, Goldberg MS, Pope CA III, Burnett RT. Long-term fine particulate matter exposure and mortality from diabetes in Canada. Diabetes Care. 2013;36:3313-3320. doi: 10.2337/dc12-2189.
8. Pope CA III, Turner MC, Burnett RT, Jerrett M, Gapstur SM, Diver WR, Krewski D, Brook RD. Relationships between fine particulate air pollution, cardiometabolic disorders, and cardiovascular mortality. Circ Res. 2015;116:108-115. doi: 10.1161/CIRCRESAHA.116.305060.
9. Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71-77. doi: 10.1161/01. CIR.0000108927.80044.7F.
10. Pope CA III, Ezzati M, Dockery DW. Fine-particulate air pollution and life expectancy in the United States. N Engl J Med. 2009;360:376-386. doi: 10.1056/NEJMsa0805646.
11. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med. 2000;343:1742-1749. doi: 10.1056/NEJM200012143432401.
12. Mustafic H, Jabre P, Caussin C, Murad MH, Escolano S, Tafflet M, Périer MC, Marijon E, Vernerey D, Empana JP, Jouven X. Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA. 2012;307:713-721. doi: 10.1001/jama.2012.126.
13. Shah AS, Lee KK, McAllister DA, Hunter A, Nair H, Whiteley W, Langrish JP, Newby DE, Mills NL. Short term exposure to air pollution and stroke: systematic review and meta-analysis. BMJ. 2015;350:h1295.
14. Pope CA III, Muhlestein JB, May HT, Renlund DG, Anderson JL, Horne BD. Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation. 2006;114:2443-2448. doi: 10.1161/ CIRCULATIONAHA.106.636977.
15. Rich DQ, Kipen HM, Zhang J, Kamat L, Wilson AC, Kostis JB. Triggering of transmural infarctions, but not nontransmural infarctions, by ambient fine particles. Environ Health Perspect. 2010;118:1229-1234. doi: 10.1289/ehp.0901624.
16. Pope CA, Muhlestein JB, Anderson JL, Cannon JB, Hales NM, Meredith KG, Le V, Horne BD. Short-term exposure to fine particulate matter air pollution is preferentially associated with the risk of ST-segment elevation acute coronary events. J Am Heart Assoc. 2015;4:. doi: 10.1161/ JAHA.115.002506.
17. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260. doi: 10.1016/ S0140-6736(12)61766-8.
18. O'Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, Horton ES, Schwartz J. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005;111:2913-2920. doi: 10.1161/ CIRCULATIONAHA.104.517110.
19. Krishnan RM, Adar SD, Szpiro AA, Jorgensen NW, Van Hee VC, Barr RG, O'Neill MS, Herrington DM, Polak JF, Kaufman JD. Vascular responses to long-and short-term exposure to fine particulate matter: MESA Air (Multi-Ethnic Study of Atherosclerosis and Air Pollution). J Am Coll Cardiol. 2012;60:2158-2166. doi: 10.1016/j.jacc.2012.08.973.
20. Schneider A, Neas LM, Graff DW, Herbst MC, Cascio WE, Schmitt MT, Buse JB, Peters A, Devlin RB. Association of cardiac and vascular changes with ambient PM2.5 in diabetic individuals. Part Fibre Toxicol. 2010;7:14. doi: 10.1186/1743-8977-7-14.
21. Siponen T, Yli-Tuomi T, Aurela M, Dufva H, Hillamo R, Hirvonen MR, Huttunen K, Pekkanen J, Pennanen A, Salonen I, Tiittanen P, Salonen RO, Lanki T. Source-specific fine particulate air pollution and systemic inflammation in ischaemic heart disease patients. Occup Environ Med. 2015;72:277-283. doi: 10.1136/oemed-2014-102240.
22. Hajat A, Allison M, Diez-Roux AV, Jenny NS, Jorgensen NW, Szpiro AA, Vedal S, Kaufman JD. Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA). Epidemiology. 2015;26:310-320. doi: 10.1097/ EDE.0000000000000267.
23. Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, Montesanti R, Di Sciascio G. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation. 2005;111:70-75. doi: 10.1161/01.CIR.0000151308.06673.D2.
24. Weiner SD, Ahmed HN, Jin Z, Cushman M, Herrington DM, Nelson JC, Di Tullio MR, Homma S. Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA). Heart. 2014;100:862-866. doi: 10.1136/heartjnl-2013-304893.
25. Tsuchiya K, Nakayama C, Iwashima F, Sakai H, Izumiyama H, Doi M, Hirata Y. Advanced endothelial dysfunction in diabetic patients with multiple risk factors; importance of insulin resistance. J Atheroscler Thromb. 2007;14:303-309.
26. Henry RM, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Kamp O, Bouter LM, Stehouwer CD. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study. Atherosclerosis. 2004;174:49-56. doi: 10.1016/j.atherosclerosis.2004.01.002.
27. Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost. 2010;36:907-916. doi: 10.1055/s-0030-1267044.
28. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, Boulanger CM. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011;109:593-606. doi: 10.1161/CIRCRESAHA.110.233163.
29. Suades R, Padró T, Badimon L. The Role of Blood-Borne Microparticles in Inflammation and Hemostasis. Semin Thromb Hemost. 2015;41:590-606. doi: 10.1055/s-0035-1556591.
30. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol. 2011;31:27-33. doi: 10.1161/ ATVBAHA.110.218123.
31. Schiro A, Wilkinson FL, Weston R, Smyth JV, Serracino-Inglott F, Alexander MY. Endothelial microparticles as conveyors of information in atherosclerotic disease. Atherosclerosis. 2014;234:295-302. doi: 10.1016/j.atherosclerosis.2014.03.019.
32. van Eeden SF, Tan WC, Suwa T, Mukae H, Terashima T, Fujii T, Qui D, Vincent R, Hogg JC. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med. 2001;164:826-830. doi: 10.1164/ ajrccm.164.5.2010160.
33. Shoenfelt J, Mitkus RJ, Zeisler R, Spatz RO, Powell J, Fenton MJ, Squibb KA, Medvedev AE. Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter. J Leukoc Biol. 2009;86:303-312. doi: 10.1189/jlb.1008587.
34. Alfaro-Moreno E, Torres V, Miranda J, Martínez L, García-Cuellar C, Nawrot TS, Vanaudenaerde B, Hoet P, Ramírez-López P, Rosas I, Nemery B, Osornio-Vargas AR. Induction of IL-6 and inhibition of IL-8 secretion in the human airway cell line Calu-3 by urban particulate matter collected with a modified method of PM sampling. Environ Res. 2009;109:528-535. doi: 10.1016/j.envres.2009.02.010.
35. Huang SL, Hsu MK, Chan CC. Effects of submicrometer particle compositions on cytokine production and lipid peroxidation of human bronchial epithelial cells. Environ Health Perspect. 2003;111:478-482.
36. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003;109:175-180.
37. Lee ST, Chu K, Jung KH, Kim JM, Moon HJ, Bahn JJ, Im WS, Sunwoo J, Moon J, Kim M, Lee SK, Roh JK. Circulating CD62E+ microparticles and cardiovascular outcomes. PLoS One. 2012;7:e35713. doi: 10.1371/ journal.pone.0035713.
38. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, Strulovici-Barel Y, Mezey JG, Crystal RG. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med. 2011;184:224-232. doi: 10.1164/rccm.201012-2061OC.
39. Eelen G, de Zeeuw P, Simons M, Carmeliet P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 2015;116:1231-1244. doi: 10.1161/CIRCRESAHA.116.302855.
40. Gospodarowicz D, Brown KD, Birdwell CR, Zetter BR. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol. 1978;77:774-788.
41. Robinson RA, Teneyck CJ, Hart MN. Growth control in cerebral microvessel-derived endothelial cells. Brain Res. 1986;384:114-120.
42. Smith S, Francis R, Guilbert L, Baker PN. Growth factor rescue of cytokine mediated trophoblast apoptosis. Placenta. 2002;23:322-330. doi: 10.1053/plac.2001.0783.
43. Bruns CJ, Solorzano CC, Harbison MT, Ozawa S, Tsan R, Fan D, Abbruzzese J, Traxler P, Buchdunger E, Radinsky R, Fidler IJ. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res. 2000;60:2926-2935.
44. Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A. RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis. 2012;15:727-744. doi: 10.1007/s10456-012-9285-x.
45. Suffee N, Richard B, Hlawaty H, Oudar O, Charnaux N, Sutton A. Angiogenic properties of the chemokine RANTES/CCL5. Biochem Soc Trans. 2011;39:1649-1653. doi: 10.1042/BST20110651.
46. Caunt M, Hu L, Tang T, Brooks PC, Ibrahim S, Karpatkin S. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res. 2006;66:4125-4132. doi: 10.1158/0008-5472. CAN-05-2570.
47. Fimmel S, Devermann L, Herrmann A, Zouboulis C. GRO-alpha: a potential marker for cancer and aging silenced by RNA interference. Ann N Y Acad Sci. 2007;1119:176-189. doi: 10.1196/annals.1404.016.
48. Reinders ME, Sho M, Robertson SW, Geehan CS, Briscoe DM. Proangiogenic function of CD40 ligand-CD40 interactions. J Immunol. 2003;171:1534-1541.
49. Dormond O, Contreras AG, Meijer E, Datta D, Flynn E, Pal S, Briscoe DM. CD40-induced signaling in human endothelial cells results in mTORC2-and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. J Immunol. 2008;181:8088-8095.
50. Gangur V, Birmingham NP, Thanesvorakul S, Joseph S. CCR3 and CXCR3 as drug targets for allergy: principles and potential. Curr Drug Targets Inflamm Allergy. 2003;2:53-62.
51. Bodnar RJ, Yates CC, Wells A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res. 2006;98:617-625. doi: 10.1161/01. RES.0000209968.66606.10.
52. Qi XF, Kim DH, Yoon YS, Jin D, Huang XZ, Li JH, Deung YK, Lee KJ. Essential involvement of cross-talk between IFN-gamma and TNF-alpha in CXCL10 production in human THP-1 monocytes. J Cell Physiol. 2009;220:690-697. doi: 10.1002/jcp.21815.
53. Hohensinner PJ, Rychli K, Zorn G, Hülsmann M, Berger R, Mörtl D, Richter B, Huber K, Wojta J, Pacher R, Niessner A. Macrophagemodulating cytokines predict adverse outcome in heart failure. Thromb Haemost. 2010;103:435-441. doi: 10.1160/TH09-06-0399.
54. Cavusoglu E, Marmur JD, Yanamadala S, Chopra V, Hegde S, Nazli A, Singh KP, Zhang M, Eng C. Elevated baseline plasma IL-8 levels are an independent predictor of long-term all-cause mortality in patients with acute coronary syndrome. Atherosclerosis. 2015;242:589-594. doi: 10.1016/j.atherosclerosis.2015.08.022.
55. Edsfeldt A, Grufman H, Asciutto G, Nitulescu M, Persson A, Nilsson M, Nilsson J, Gonçalves I. Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques. Atherosclerosis. 2015;241:443-449. doi: 10.1016/j.atherosclerosis.2015.05.019.
56. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 1994;91:3652-3656.
57. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFNgamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 2002;168:3195-3204.
58. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol. 2002;160:673-680. doi: 10.1016/S0002-9440(10)64887-0.
59. Levitzky YS, Guo CY, Rong J, Larson MG, Walter RE, Keaney JF Jr, Sutherland PA, Vasan A, Lipinska I, Evans JC, Benjamin EJ. Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis. 2008;201:217-224. doi: 10.1016/j. atherosclerosis.2007.12.058.
60. de-Torres JP, Blanco D, Alcaide AB, Seijo LM, Bastarrika G, Pajares MJ, Muñoz-Barrutia A, Ortiz-de-Solorzano C, Pio R, Campo A, Montes U, Segura V, Pueyo J, Montuenga LM, Zulueta JJ. Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1ra. PLoS One. 2013;8:e60260. doi: 10.1371/ journal.pone.0060260.
61. Andelid K, Tengvall S, Andersson A, Levänen B, Christenson K, Jirholt P, Åhrén C, Qvarfordt I, Ekberg-Jansson A, Lindén A. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization? Int J Chron Obstruct Pulmon Dis. 2015;10:689-702. doi: 10.2147/COPD.S76273.
62. Symvoulakis EK, Vardavas CI, Fountouli P, Stavroulaki A, Antoniou KM, Duijker G, Tzatzarakis MN, Sfiridaki K, Bolonaki E, Alegakis T, Tsatsakis AM. Time interval from cigarette smoke exposure to blood donation and markers of inflammation: should a smoking cut-off be designated? Xenobiotica. 2010;40:613-620. doi: 10.3109/00498254.2010.500745.
63. Conklin BS, Zhao W, Zhong DS, Chen C. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol. 2002;160:413-418. doi: 10.1016/S0002-9440(10)64859-6.
64. Garlichs CD, Cicha I, Raaz D, Meyer L, Stumpf C, Klinghammer L, Yilmaz A, Daniel WG. CD40/CD154 system and pro-inflammatory cytokines in young healthy male smokers without additional risk factors for atherosclerosis. Inflamm Res. 2009;58:306-311. doi: 10.1007/ s00011-008-8084-8.